OneMedNet Announces Board Member Transition to Drive Growth Post-IPO
October 02 2024 - 8:30AM
OneMedNet Corporation (Nasdaq: ONMD) (“OneMedNet” or the
“Company”), the leading curator of regulatory-grade Real World Data
(RWD), is pleased to announce a strategic refresh of its Board of
Directors following the successful transition to a publicly traded
entity. This move reinforces our commitment to dynamic leadership
and active engagement as we accelerate growth in this new phase.
We extend our heartfelt gratitude to Paul
Casey, and Erkan Akyuz for their
invaluable contributions during a pivotal time in our company's
history. Their leadership and guidance were instrumental in
achieving our IPO, laying a strong foundation as OneMedNet entered
the public markets. We thank them for their service and wish them
the best in their future endeavors.
In alignment with our vision for the future, we are excited to
welcome two distinguished individuals to our Board.
Jair Clarke, currently serves as Executive
Advisor to the Chairman at World Wide Technology (WWT), holds the
position of CEO at Laigic and is a board member of Xponential
(NYSE:XPOF) that is focused on health and wellness. His career also
includes a tenure as a Global CTO at Microsoft, where he was
pivotal in shaping the company's technological direction. Prior to
this, he led Disney’s Big Data, technology strategy and digital
intelligence and co-led IBM Watson’s strategy and delivery.
Jair’s experience positions him to contribute to the following
business priorities:
- Market Expansion and Business Development:
Leveraging his extensive network and insights in AI and digital
intelligence to explore new markets and forge strategic
partnerships.
- Technology Platform Enhancement: Bringing his
expertise from Microsoft, Disney and IBM Watson to refine OneMedNet
technology solutions.
- Operational Efficiency: Focusing on greater
effectiveness and scalability.
Sherry Coonse McCraw, currently the VP of Human
Resources and former CFO of BMW North America, brings a diverse
background in both finance and human capital strategy. As the new
head of our audit committee, her expertise will be critical in:
- Financial Oversight: Ensuring robust financial
governance and strategic planning.
- Transparency and Accountability: Maintaining
integrity and trust as we scale our operations.
- Human Resources Leadership: Combining her HR
and financial experience to align human capital strategies with
organizational goals.
"OneMedNet is at an exciting juncture, and the addition of
Sherry and Jair to our Board is a testament to our commitment to
excellence and innovation," said Jeffrey Yu, MD, Founder
and Chairman of OneMedNet. “We are grateful for the
foundational work of Paul and Erkan, and with Sherry and Jair
onboard, we are well-positioned to drive our company towards new
heights.”
This transition reflects our strategic focus on enhancing
corporate governance, leveraging diverse expertise, and ensuring
that our Board is equipped to guide OneMedNet through its next
phase of growth and innovation.
About OneMedNet Corporation
OneMedNet provides innovative solutions that
unlock the significant value contained within the Real-World Data
(“RWD”) repositories of over 1,400 healthcare system and provider
sites that currently comprise its iRWD™ network. OneMedNet’s
proprietary iRWD™ platform provides secure, comprehensive
management of diverse clinical data types, including electronic
health records, laboratory results, and uniquely, medical imaging.
Employing its robust iRWD™ platform, the Company securely
de-identifies, searches, and curates the clinical data, bringing a
wealth of internal and third-party research opportunities to its
drug, medical device and imaging/diagnostic AI development
customers.
OneMedNet’s platform is designed to meet the
clinical requirements necessary across various domains, including
but not limited to rare diseases, oncology, and cardiology. The
Company is committed to delivering precise and robust research
support services that span the entire continuum of care. This
commitment is a cornerstone of OneMedNet’s strategy to enhance
patient outcomes and help pave the next wave of healthcare
innovation. For more information, please visit
www.onemednet.com.
Cautionary Note Regarding
Forward-Looking Statements
This press release contains forward-looking
statements. In addition, from time to time, we or our
representatives may make forward-looking statements orally or in
writing. We base these forward-looking statements on our
expectations and projections about future events, which we derive
from the information currently available to us. Such
forward-looking statements relate to future events or our future
performance, including: our financial performance and projections;
our growth in revenue and earnings; and our business prospects and
opportunities. You can identify forward-looking statements by those
that are not historical in nature, particularly those that use
terminology such as "may," "should," "expects," "anticipates,"
"contemplates," "estimates," "believes," "plans," "projected,"
"predicts," "potential," or "hopes" or the negative of these or
similar terms. In evaluating these forward-looking statements, you
should consider various factors, including: our ability to change
the direction of OneMedNet; our ability to keep pace with new
technology and changing market needs; and the competitive
environment of our business. These and other factors may cause our
actual results to differ materially from any forward-looking
statement. Forward-looking statements are only predictions. The
forward-looking events discussed in this press release and other
statements made from time to time by us or our representatives, may
not occur, and actual events and results may differ materially and
are subject to risks, uncertainties, and assumptions about us. We
are not obligated to publicly update or revise any forward-looking
statement, whether as a result of uncertainties and assumptions,
the forward-looking events discussed in this press release and
other statements made from time to time by us or our
representatives might not occur.
OneMedNet
Contacts:
Michael Wong, Director
of MarketingPhone: 800.918.7189Email:
michael.wong@onemednet.com
SOURCE: ONEMEDNET
CORPORATION
OneMedNet (NASDAQ:ONMD)
Historical Stock Chart
From Nov 2024 to Dec 2024
OneMedNet (NASDAQ:ONMD)
Historical Stock Chart
From Dec 2023 to Dec 2024